What is the address of Dr. Sophie Boeckx Oftalmologie?

The registered office of Dr. Sophie Boeckx Oftalmologie is located at Martelarenstraat 74, 2400 Mol.

Is Dr. Sophie Boeckx Oftalmologie still active?

Yes. According to the CBE (29 September 2026) Dr. Sophie Boeckx Oftalmologie is active, legal situation “Normale toestand”, started on 8 October 2020.

Is Dr. Sophie Boeckx Oftalmologie registered on Peppol?

Yes, Dr. Sophie Boeckx Oftalmologie is registered on the Peppol network with ID 0208:0755852902.

What is the enterprise number of Dr. Sophie Boeckx Oftalmologie?

The enterprise number of Dr. Sophie Boeckx Oftalmologie is BE0755852902.

When was Dr. Sophie Boeckx Oftalmologie founded?

Dr. Sophie Boeckx Oftalmologie was founded on 8 October 2020.

Who are the directors of Dr. Sophie Boeckx Oftalmologie?

According to the 2025 annual accounts, the directors of Dr. Sophie Boeckx Oftalmologie are: Sophie BOECKX.

Is Dr. Sophie Boeckx Oftalmologie a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 8 October 2020; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account; 2 establishments in the CBE.

How much profit did Dr. Sophie Boeckx Oftalmologie make in 2025?

Dr. Sophie Boeckx Oftalmologie posted a profit after taxes of € 252,636 in financial year 2025.

What is the revenue of Dr. Sophie Boeckx Oftalmologie?

As a small company, Dr. Sophie Boeckx Oftalmologie is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 333,449.

Dr. Sophie Boeckx Oftalmologie (Private Limited) - Mol

Dossier Dr. Sophie Boeckx Oftalmologie, printed on 29 September 2026 from databakkes.be/en/0755852902/dr-sophie-boeckx-oftalmologie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr. Sophie Boeckx Oftalmologie from Mol, company number BE0755852902, closed financial year 2025 with a result of € 252,636 after tax. For that financial year Dr. Sophie Boeckx Oftalmologie recorded a gross margin of € 333,449 and equity of € 307,058. Compared with financial year 2024, the result moved from € 68,923 to € 252,636. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 30, 2026.

What it is worth Growing

€ 307,058

▲ € 252,636 vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 252,636

▲ 267% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 21,610

▼ 76% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 304,558.

People and assets in 2025

Wage cost

€ 3

▼ 99% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 16,176

▲ 271% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 5,613

▼ 45% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 111,372

▲ 54% vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 87,450 Gross margin 2022: € 87,450 First fiscal year in the series	€ 230,242 Gross margin 2023: € 230,242 ▲ 163% vs 2022 (€ 87,450) Favourable step	€ 76,480 Gross margin 2024: € 76,480 ▼ 67% vs 2023 (€ 230,242) Unfavourable step	€ 333,449 Gross margin 2025: € 333,449 ▲ € 256,969 vs 2024 (€ 76,480) Favourable step	▲ € 256,969
Profit after taxes	€ 57,370 Profit after taxes 2022: € 57,370 First fiscal year in the series	€ 163,999 Profit after taxes 2023: € 163,999 ▲ 186% vs 2022 (€ 57,370) Favourable step	€ 68,923 Profit after taxes 2024: € 68,923 ▼ 58% vs 2023 (€ 163,999) Unfavourable step	€ 252,636 Profit after taxes 2025: € 252,636 ▲ 267% vs 2024 (€ 68,923) Favourable step	▲ 267%
Equity	€ 16,500 Equity 2022: € 16,500 First fiscal year in the series	€ 180,499 Equity 2023: € 180,499 ▲ € 163,999 vs 2022 (€ 16,500) Favourable step	€ 54,422 Equity 2024: € 54,422 ▼ 70% vs 2023 (€ 180,499) Unfavourable step	€ 307,058 Equity 2025: € 307,058 ▲ € 252,636 vs 2024 (€ 54,422) Favourable step	▲ € 252,636
Total debts	€ 140,271 Total debts 2022: € 140,271 First fiscal year in the series	€ 79,964 Total debts 2023: € 79,964 ▼ 43% vs 2022 (€ 140,271) Favourable step	€ 277,443 Total debts 2024: € 277,443 ▲ 247% vs 2023 (€ 79,964) Unfavourable step	€ 116,985 Total debts 2025: € 116,985 ▼ 58% vs 2024 (€ 277,443) Favourable step	▼ 58%
Cash	€ 34 Cash 2022: € 34 First fiscal year in the series	€ 20,126 Cash 2023: € 20,126 ▲ € 20,092 vs 2022 (€ 34) Favourable step	€ 89,151 Cash 2024: € 89,151 ▲ € 69,024 vs 2023 (€ 20,126) Favourable step	€ 21,610 Cash 2025: € 21,610 ▼ 76% vs 2024 (€ 89,151) Unfavourable step	▼ 76%
Retained profit	€ 14,000 Retained profit 2022: € 14,000 First fiscal year in the series	€ 177,999 Retained profit 2023: € 177,999 ▲ € 163,999 vs 2022 (€ 14,000) Favourable step	€ 51,922 Retained profit 2024: € 51,922 ▼ 71% vs 2023 (€ 177,999) Unfavourable step	€ 304,558 Retained profit 2025: € 304,558 ▲ € 252,636 vs 2024 (€ 51,922) Favourable step	▲ € 252,636
Dividend	€ 43,370 Dividend 2022: € 43,370 First fiscal year in the series	€ 0 Dividend 2023: € 0 ▼ 100% vs 2022 (€ 43,370) Unchanged	€ 195,000 Dividend 2024: € 195,000 Unchanged (€ 0) Unchanged	€ 0 Dividend 2025: € 0 ▼ 100% vs 2024 (€ 195,000) Unchanged	▼ 100%
Balance sheet total	€ 156,771 Balance sheet total 2022: € 156,771 First fiscal year in the series	€ 260,463 Balance sheet total 2023: € 260,463 ▲ 66% vs 2022 (€ 156,771) Unchanged	€ 331,865 Balance sheet total 2024: € 331,865 ▲ 27% vs 2023 (€ 260,463) Unchanged	€ 424,043 Balance sheet total 2025: € 424,043 ▲ 28% vs 2024 (€ 331,865) Unchanged	▲ 28%

Key figures of Dr. Sophie Boeckx Oftalmologie, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. Sophie Boeckx Oftalmologie?

What happened at Dr. Sophie Boeckx Oftalmologie in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 30, 2026 New annual accounts for financial year 2025: profit of € 252,636 (▲ 267% vs 2024). Source: NBB ↗
Oct 8, 2020 New establishment in Mol. KBO
Oct 8, 2020 New establishment in Mol. KBO
Oct 8, 2020 Start of the company according to the CBE. KBO

In short

From € 57,370 profit in 2022 to € 252,636 profit in 2025.

Paid € 174,279 in corporate taxes since 2022.

Best year ever: 2025, with € 252,636 profit.

Paid out € 238,370 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. Sophie Boeckx Oftalmologie? We notify you, reason included.

Follow Dr. Sophie Boeckx Oftalmologie

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit